Literature DB >> 21845539

Astroglia disturbances during development of the central nervous system in fetuses with Down's syndrome.

Grzegorz Zdaniuk1, Teresa Wierzba-Bobrowicz, Grażyna M Szpak, Tomasz Stępień.   

Abstract

Down's syndrome (DS), caused by aneuploidy of chromosome 21, is the most common chromosomal disorder. The most significant symptom of this disorder is mental retardation. Neuropathological changes found in the DS central nervous system (CNS), such as reduced number of neurons, alteration of synapses and synaptic spines or delayed myelination have been widely described. But there are only a few studies of DS-related glia disturbances. A growing number of astroglia new functions have recently been described. In our study we compared the number of astrocytes and radial glial cells in the frontal lobe of DS fetuses at 18-20 weeks of gestation with that observed in age-matched controls. We found a substantially increased number of glial fibrillary acid protein (GFAP) positive cells in all age range samples of DS brains. We also noticed that in our study astrocytes in DS brains seem to be morphologically more mature than in controls of corresponding age. The same observation was made for radial glia. Taking into consideration the role played by astroglia during CNS development we believe that any change in their number, reduced or increased, can affect CNS development and lead to disturbances of both neurogenesis and synaptogenesis. A possible correlation between the increased number of astroglia and disturbances in CNS development is discussed.

Entities:  

Mesh:

Year:  2011        PMID: 21845539

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  19 in total

1.  Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome.

Authors:  Tomo Tarui; Kiho Im; Neel Madan; Rajeevi Madankumar; Brian G Skotko; Allie Schwartz; Christianne Sharr; Steven J Ralston; Rie Kitano; Shizuko Akiyama; Hyuk Jin Yun; Ellen Grant; Diana W Bianchi
Journal:  Cereb Cortex       Date:  2020-01-10       Impact factor: 5.357

2.  Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

Authors:  Sarah E Lee; Monica Duran-Martinez; Sabina Khantsis; Diana W Bianchi; Faycal Guedj
Journal:  Trends Mol Med       Date:  2019-11-07       Impact factor: 11.951

3.  Increasing astrogenesis in the developing hippocampus induces autistic-like behavior in mice via enhancing inhibitory synaptic transmission.

Authors:  Juan Chen; Xiao-Lin Ma; Hui Zhao; Xiao-Yu Wang; Min-Xin Xu; Hua Wang; Tian-Qi Yang; Cheng Peng; Shuang-Shuang Liu; Man Huang; Yu-Dong Zhou; Yi Shen
Journal:  Glia       Date:  2021-09-09       Impact factor: 8.073

4.  Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.

Authors:  Lisi Flores-Aguilar; M Florencia Iulita; Olivia Kovecses; Maria D Torres; Sarah M Levi; Yian Zhang; Manor Askenazi; Thomas Wisniewski; Jorge Busciglio; A Claudio Cuello
Journal:  Brain       Date:  2020-12-01       Impact factor: 13.501

Review 5.  Mechanisms of astrocyte development and their contributions to neurodevelopmental disorders.

Authors:  Steven A Sloan; Ben A Barres
Journal:  Curr Opin Neurobiol       Date:  2014-03-30       Impact factor: 6.627

6.  Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics.

Authors:  Blandine Ponroy Bally; W Todd Farmer; Emma V Jones; Selin Jessa; J Benjamin Kacerovsky; Alexandre Mayran; Huashan Peng; Julie L Lefebvre; Jacques Drouin; Arnold Hayer; Carl Ernst; Keith K Murai
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

Review 7.  Human astrocytes in the diseased brain.

Authors:  Elena Dossi; Flora Vasile; Nathalie Rouach
Journal:  Brain Res Bull       Date:  2017-02-13       Impact factor: 4.077

8.  A human isogenic iPSC-derived cell line panel identifies major regulators of aberrant astrocyte proliferation in Down syndrome.

Authors:  Keiji Kawatani; Toshihiko Nambara; Nobutoshi Nawa; Hidetaka Yoshimatsu; Haruna Kusakabe; Katsuya Hirata; Akira Tanave; Kenta Sumiyama; Kimihiko Banno; Hidetoshi Taniguchi; Hitomi Arahori; Keiichi Ozono; Yasuji Kitabatake
Journal:  Commun Biol       Date:  2021-06-14

Review 9.  Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics.

Authors:  Nicole Créau
Journal:  Neural Plast       Date:  2012-07-12       Impact factor: 3.599

Review 10.  Potential Role of JAK-STAT Signaling Pathway in the Neurogenic-to-Gliogenic Shift in Down Syndrome Brain.

Authors:  Han-Chung Lee; Kai-Leng Tan; Pike-See Cheah; King-Hwa Ling
Journal:  Neural Plast       Date:  2016-01-12       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.